title: [A young woman with granulomatous mastitis: a corynebacteria may be involved in the pathogenesis of these disease].
abstract: BACKGROUND
  The granulomatous mastitis is an inflammatory pseudotumor of the breast of which evolution benign but likely to generate important morphological after-effects among young women. This anatomoclinic entity of dubious etiology until these last years poses a problem of differential diagnosis with other etiologies of granulomatosis and especially with inflammatory carcinoma of the breast. The infectious theory is actually based on solid arguments and mainly explains the physiopathology of this affection.
  
  
  CONCLUSIONS
  A 26 years old young woman developed an inflammatory tumor of the left breast of which the catch of load by surgery and an antibiotherapy had shown trailing local continuations and of the esthetic after-effects. One year later, a very inflammatory repetition on the level of the right breast was dealt with in a different way: by steroids and immunomodulating drugs associated with iterative punctures with the purulent collections, the objective being to be less dilapidating that left side. The initial answer was rather favorable and encouraging but the purulent reappearance bulky granulomas with sinus way made reconsider the therapeutic attitude and antibiotics were undertaken after description of a lipophilic corynebactery in the material of puncture (Corynebacteria kroppenstedtii). The effectiveness of the amoxicilline introduced on the data of the antibiogram was undeniable.
  
  
  CONCLUSIONS
  This observation illustrates the therapeutic and diagnostic difficulties of an exceptional affection. Potentially accessible to antibiotics it generally requires a joint surgical assumption of responsibility, at the same time to ensure the histological diagnosis but also with a therapeutic aim. The interest of steroids and the immunomodulation by methotrexate is debatable, these treatments cannot however be conceived without antibiotherapy and sometimes surgery.
authors.affiliation: Service de Médecine Interne, Centre Hospitalier Saint-Morand, 68134 Altkirch cedex, France. pierre.kieffer@ch-altkirch.fr
authors.forename: P
authors.initials: P
authors.lastname: Kieffer
authors.forename: R
authors.initials: R
authors.lastname: Dukic
authors.forename: M
authors.initials: M
authors.lastname: Hueber
authors.forename: C
authors.initials: C
authors.lastname: Kieffer
authors.forename: M
authors.initials: M
authors.lastname: Bouhala
authors.forename: P
authors.initials: P
authors.lastname: Riegel
authors.forename: J-M
authors.initials: JM
authors.lastname: Wilhelm
mesh_terms: D000328:Adult; D000658:Amoxicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003352:Corynebacterium / Q000145:classification / Q000302:isolation & purification; D003354:Corynebacterium Infections / Q000175:diagnosis*; D003937:Diagnosis, Differential; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006104:Granuloma, Plasma Cell / Q000175:diagnosis / Q000382:microbiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008413:Mastitis / Q000175:diagnosis / Q000382:microbiology*; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011677:Punctures; D012008:Recurrence
chemical_list: D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D000658:Amoxicillin; D011241:Prednisone; D008727:Methotrexate